Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Clinical trial NCT00003362 · COMPLETED

Trial details

NCT number: NCT00003362
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1998-05-01
Primary completion: 2001-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.